Evidence map

ArticleNature metabolism2025

A salute to innovation: exenatide in diabetes and obesity drug development at Amylin Pharmaceuticals.

James L Trevaskis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40999040